Deep Cuts to Cancer Research
Budget Plan Risks Hard-Fought Research Gains President Trump’s budget proposal for FY 2018 calls for a drastic 20% cut to [...]
Esophageal Cancer Genome
ECAN’s President and CEO Mindy Mintz Mordecai recently had the opportunity to interview Dr. Adam Bass, co-chair of the [...]
FDA Petition for Cancer Warnings
ECAN petitioned the U.S. Food and Drug Administration (FDA) for new labels on over-the-counter (OTC) heartburn medications warning of the [...]